Brent Dickinson

2.6k total citations
24 papers, 1.8k citations indexed

About

Brent Dickinson is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Brent Dickinson has authored 24 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 8 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Brent Dickinson's work include MicroRNA in disease regulation (7 papers), Ophthalmology and Eye Disorders (6 papers) and Thyroid Disorders and Treatments (5 papers). Brent Dickinson is often cited by papers focused on MicroRNA in disease regulation (7 papers), Ophthalmology and Eye Disorders (6 papers) and Thyroid Disorders and Treatments (5 papers). Brent Dickinson collaborates with scholars based in United States, United Kingdom and Canada. Brent Dickinson's co-authors include Eva van Rooij, Anita G. Seto, Rusty L. Montgomery, Hillary M. Semus, Christianna Stack, Thomas G. Hullinger, Joshua M. Lynch, Eric N. Olson, Joshua M. Hare and Linda Pestano and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

Brent Dickinson

23 papers receiving 1.8k citations

Peers

Countries citing papers authored by Brent Dickinson

Since Specialization

Citations

This map shows the geographic impact of Brent Dickinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brent Dickinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brent Dickinson more than expected).

Fields of papers citing papers by Brent Dickinson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brent Dickinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brent Dickinson. The network helps show where Brent Dickinson may publish in the future.

Co-authorship network of co-authors of Brent Dickinson

This figure shows the co-authorship network connecting the top 25 collaborators of Brent Dickinson. A scholar is included among the top collaborators of Brent Dickinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brent Dickinson. Brent Dickinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preclinical pharmacology, pharmacokinetics, and pharmacodynamics of veligrotug, a full antagonist antibody to the IGF-1 receptor in development for thyroid eye disease 2025 ·mAbs ·Rachel M. Kaplan, (unknown), Jordan C. Tsai, Brent Dickinson, (unknown), Kelly Foster, Vahe Bedian	1
2	6461 VRDN-003, A Full Antagonist Antibody To The IGF-1 Receptor For Thyroid Eye Disease (TED): Safety And Pharmacokinetic Results Of Subcutaneous Administration In Healthy Volunteers 2024 ·Journal of the Endocrine Society ·Kelly Foster, Brent Dickinson, (unknown), Jyothi Vijayaraghavan, (unknown), Vahe Bedian	0
3	6461 VRDN-003, a Full Antagonist Antibody to the IGF-1 Receptor for Thyroid Eye Disease (TED): Safety and Pharmacokinetic Results of Subcutaneous Administration in Healthy Volunteers 2024 ·Journal of the Endocrine Society ·Kelly Foster, Brent Dickinson, (unknown), Jyothi Vijayaraghavan, (unknown), Vahe Bedian	1
4	FRI546 VRDN-001, A Full Antagonist Antibody To IGF-1 Receptor In Development For Thyroid Eye Disease (TED): Pharmacodynamic Responses In Healthy Volunteers And Patients With Active TED 2023 ·Journal of the Endocrine Society ·Kelly Foster, Brent Dickinson, (unknown), (unknown), Vahe Bedian, Barrett Katz	1
5	Phase 1 Safety and Pharmacodynamic Results of VRDN-001, a Full Antagonist Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R) in Development for Thyroid Eye Disease (TED) (P3-9.007) 2023 ·Neurology ·(unknown), Barrett Katz, (unknown), Denis O’Shaughnessy, Brent Dickinson, Kelly Foster, Vahe Bedian	2
6	A lung targeted miR-29 mimic as a therapy for pulmonary fibrosis 2022 ·EBioMedicine ·Maurizio Chioccioli, Subhadeep Roy, (unknown), Linda Pestano, Brent Dickinson, Kevin M. Rigby, Jose D. Herazo‐Maya, Gísli Jenkins, (unknown), Gauri Saini, Simon R. Johnson, Rebecca Braybrooke, (unknown), Maor Sauler, (unknown), Shuizi Ding, (unknown), Nachelle Aurelien, Rusty L. Montgomery, Naftali Kaminski	76
7	A synthetic microRNA‐92a inhibitor (MRG‐110) accelerates angiogenesis and wound healing in diabetic and nondiabetic wounds 2018 ·Wound Repair and Regeneration ·Corrie L. Gallant‐Behm, Joseph Piper, Brent Dickinson, (unknown), Linda Pestano, Aimee L. Jackson	121
8	Feasibility, distribution, and efficacy of an inhaled oligonucleotide mimic of miR-29 for pulmonary fibrosis induced by bleomycin in rats 2017 ·Rusty L. Montgomery, Guoying Yu, Farida Ahangari, Jose D. Herazo‐Maya, Linda Pestano, (unknown), Brent Dickinson, (unknown), Corrie L. Gallant‐Behm, (unknown), Philip J. Kuehl, Jacob D. McDonald, Naftali Kaminski	1
9	LB948 Pharmacodynamic activity of a microRNA-29b mimic (MRG-201) in human skin incisions 2017 ·Journal of Investigative Dermatology ·Corrie L. Gallant‐Behm, Catherine Maari, Aimee L. Jackson, Anita G. Seto, Joshua M. Lynch, Judy Ruckman, (unknown), Linda Pestano, Brent Dickinson, (unknown), (unknown), David M. Rodman, Gary G. Gordon, Paul Rubin, William S. Marshall	2
10	PH 1 TRIAL EVALUATING MRG‐106, A MICRORNA‐155 INHIBITOR, ADMINISTERED BY INTRATUMORAL, SUBCUTANEOUS, OR INTRAVENOUS DELIVERY IN CUTANEOUS T‐CELL LYMPHOMA (CTCL) PATIENTS 2017 ·Hematological Oncology ·Christiane Querfeld, Francine M. Foss, Pierluigi Porcu, (unknown), Theresa Pacheco, Bradley M. Haverkos, Ahmad Halwani, Jennifer DeSimone, Basem M. William, Lauren Pinter‐Brown, Anita G. Seto, Judy Ruckman, (unknown), Aimee L. Jackson, Brent Dickinson, (unknown), David M. Rodman, Paul Rubin, William S. Marshall	2
11	Phase 1 Study of the Safety and Efficacy of MRG-106, a Synthetic Inhibitor of microRNA-155, in CTCL Patients 2017 ·Blood ·Christiane Querfeld, Francine M. Foss, Lauren Pinter‐Brown, Pierluigi Porcu, Basem M. William, Theresa Pacheco, Bradley M. Haverkos, Youn H. Kim, Joan Guitart, Ahmad Halwani, Jennifer DeSimone, Anita G. Seto, Linda Pestano, Aimee L. Jackson, Paul J. Williams, Brent Dickinson, Judy Ruckman, Gilad S. Gordon, Paul Rubin, (unknown)	25
12	Preclinical Results Supporting Therapeutic Development of Mrg-106, an Oligonucleotide Inhibitor of Mir-155, in CTCL 2015 ·Blood ·Anita G. Seto, Xuan Beatty, Linda Pestano, Brent Dickinson, Marshelle Warren, David M. Rodman, Aimee L. Jackson	5
13	Plasma microRNAs Serve as Biomarkers of Therapeutic Efficacy and Disease Progression in Hypertension-Induced Heart Failure 2013 ·European Journal of Heart Failure ·Brent Dickinson, Hillary M. Semus, Rusty L. Montgomery, Christianna Stack, (unknown), (unknown), Joshua M. Lynch, Thomas G. Hullinger, Anita G. Seto, Eva van Rooij	141
14	MicroRNA-214 Antagonism Protects against Renal Fibrosis 2013 ·Journal of the American Society of Nephrology ·Laura Denby, (unknown), Ruifang Lu, Bryan R. Conway, (unknown), Brent Dickinson, Arin B. Aurora, John McClure, David Kipgen, Christian Delles, Eva van Rooij, Andrew H. Baker	120
15	Inhibition of miR-15 Protects Against Cardiac Ischemic Injury 2011 ·Circulation Research ·Thomas G. Hullinger, Rusty L. Montgomery, Anita G. Seto, Brent Dickinson, Hillary M. Semus, Joshua M. Lynch, (unknown), Kathryn M. Robinson, Christianna Stack, (unknown), Joshua M. Hare, Eric N. Olson, Eva van Rooij	386
16	Therapeutic Inhibition of miR-208a Improves Cardiac Function and Survival During Heart Failure 2011 ·Circulation ·Rusty L. Montgomery, Thomas G. Hullinger, Hillary M. Semus, Brent Dickinson, Anita G. Seto, Joshua M. Lynch, Christianna Stack, (unknown), Eric N. Olson, Eva van Rooij	468
17	Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication† 2005 ·Hepatology ·Dylan Morrissey, Karin S. Blanchard, (unknown), Kristi Jensen, Jennifer A. Lockridge, Brent Dickinson, James A. McSwiggen, Chandra Vargeese, Keith Bowman, (unknown), Barry Polisky, Shawn Zinnen	219
18	Selection, design, and characterization of a new potentially therapeutic ribozyme 2002 ·RNA ·Shawn Zinnen, (unknown), Mike Wilson, Brent Dickinson, Amber Beaudry, (unknown), Andrew T. Daniher, Alex B. Burgin, Leonid Beigelman	26
19	Drug interactions between oral contraceptives and antibiotics 2001 ·Obstetrics and Gynecology ·Brent Dickinson	97
20	Modulation of telomerase activity by telomere DNA-binding proteins in Oxytricha 1998 ·Genes & Development ·Stacie J. Froelich-Ammon, Brent Dickinson, Joanne M. Bevilacqua, Steve C. Schultz, Thomas R. Cech	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact